Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
11-Nov-2025 | 785 | 785 | 761 | 765.05 | 8,040 | 16,10,27,933 | 91,357 |
12-Nov-2025 | 766 | 792.9 | 766 | 776.6 | 8,798 | 27,11,19,548.85 | 2,09,018 |
13-Nov-2025 | 776.6 | 806 | 775 | 792.7 | 12,497 | 36,54,30,861.3 | 2,44,071 |
14-Nov-2025 | 792.7 | 792.7 | 772.65 | 780.4 | 6,971 | 14,57,79,219.2 | 87,797 |
17-Nov-2025 | 783 | 799.95 | 779 | 788.15 | 6,970 | 13,72,98,368.35 | 74,941 |
18-Nov-2025 | 788.15 | 803.3 | 781.6 | 797.35 | 7,192 | 15,35,79,910.1 | 70,706 |
19-Nov-2025 | 798.5 | 802.45 | 780.75 | 790.95 | 6,735 | 14,80,30,485.85 | 77,776 |
20-Nov-2025 | 794.75 | 831.9 | 786.5 | 825.75 | 14,154 | 34,63,98,036.9 | 1,92,667 |
21-Nov-2025 | 820.1 | 831 | 811.95 | 819.55 | 6,701 | 12,72,23,601.45 | 78,870 |
24-Nov-2025 | 819.55 | 820.45 | 784.9 | 793.85 | 7,293 | 19,85,89,454.9 | 1,37,702 |
25-Nov-2025 | 798 | 798 | 755 | 765.4 | 15,970 | 41,12,94,522.25 | 2,71,096 |
26-Nov-2025 | 765.4 | 784.75 | 765.35 | 778.95 | 5,370 | 11,33,80,092.2 | 62,241 |
27-Nov-2025 | 781.2 | 798 | 775 | 781.85 | 5,401 | 13,62,46,247.15 | 84,744 |
28-Nov-2025 | 783.95 | 827.85 | 777 | 823.7 | 13,617 | 33,14,63,080.45 | 1,52,417 |
01-Dec-2025 | 825 | 831.2 | 797.1 | 807.2 | 7,625 | 14,26,82,567.15 | 83,657 |
02-Dec-2025 | 809.8 | 813.2 | 791 | 793.95 | 4,326 | 9,01,08,196.1 | 62,243 |
03-Dec-2025 | 790.7 | 798.15 | 780.2 | 785.55 | 4,086 | 6,92,75,299.6 | 43,425 |
04-Dec-2025 | 782 | 795 | 777 | 786.5 | 4,986 | 10,77,66,330.15 | 55,559 |
05-Dec-2025 | 792 | 792.25 | 767.1 | 776.75 | 9,093 | 17,28,45,087.6 | 1,03,597 |
08-Dec-2025 | 778 | 782.9 | 746.4 | 752.65 | 7,903 | 14,01,80,522.7 | 93,743 |
09-Dec-2025 | 740 | 784.65 | 738.1 | 770.75 | 15,220 | 20,90,96,206.95 | 1,23,691 |
10-Dec-2025 | 765.1 | 789.65 | 763 | 771.9 | 8,937 | 9,20,69,847.8 | 39,142 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
